As of Mar 31
| +0.04 / +1.77%|
The 1 analysts offering 12-month price forecasts for Biota Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +8.70% increase from the last price of 2.30.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.